Frontlight ResearchEarly access
Trial site
Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- High blood pressure4 trials
- Pulmonary arterial hypertension4 trials
- Heart failure3 trials
- Nephrotic syndrome1 trial
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting3 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1 trial
- Actelion1 trial
- Institut De Recherches Internationales Servier IRIS1 trial
- Medical University Of Lodz1 trial
- Medical University Of Warsaw1 trial
- and 2 more
Running trials
Not yet recruiting
A study to compare heart failure medicines in one combined pill with usual care.
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure3 recruiting
- Pulmonary arterial hypertension3 recruiting
- Heart failure1 recruiting
- Nephrotic syndrome1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026